ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 503

Sjögren’s Syndrome In American Ethnic and Racial Minorities

Ann Igoe1, Christopher J. Lessard2,3, Juan-Manuel Anaya4, Astrid Rasmussen2, Kiely Grundahl5, Biji T. Kurien6,7,8, Jacen S Maier-Moore9, Lida Radfar10, John A. Ice2, Glen D. Houston11, David M. Lewis12, Donald U. Stone13, Kimberly S. Hefner14, Kathy L. Sivils2,3 and R. Hal Scofield6,8,15, 1Arthritis & Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 4Center for Autoimmune Diseases Research (CREA), Universidad del Rosario., Bogota, Colombia, 5Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, oklahoma CIty, OK, 6Oklahoma Medical Research Foundation, Oklahoma City, OK, 7U.S. Department of Veterans Affairs Medical Center, Oklahoma City, OK, 8College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 9Medicine; Arthritis & Clinical Immunology, University of Oklahoma Health Sciences Center, Oklahoma Medical Research Foundation, Department of Veterans Affairs, Oklahoma City, OK 73104, Oklahoma City, OK, 10College of Dentristry, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 11Collage of Denistry, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 12College of Dentistry, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 13Department of Ophthalmology, Dean McGee Eye Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 14Hefner Eye Care and Optical Center, Oklahoma City, OK, 15US Department of Veterans Affairs Medical Center, Oklahoma City, OK

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: African-Americans, Hispanic patients and Sjogren's syndrome

  • Tweet
  • Email
  • Print
Session Information

Title: Sjögren's Syndrome: Clinical Aspects

Session Type: Abstract Submissions (ACR)

Background/Purpose: Examine the racial and ethnic make-up of a large cohort of Sjögren’s syndrome (SS) gathered in the USA compared to the make-up found among SLE patients, as well as the clinical manifestations of SS in Black- and Hispanic-Americans.

Methods: Consecutive subjects, all of whom had dry eyes and mouth, attending a comprehensive sicca evaluation clinic underwent dental, ophthalmological and medical examinations. Subjects were classified according to the American-European Consensus Group Criteria (AECG) as well as the SICCA/ACR criteria. Furthermore, race and ethnicity were recorded based on self-report as well as NIH-defined race and ethnicity.  Laboratory and serological studies included determination of anti-Ro/La by multiple methods.

Results: Among 256 subjects classified as primary Sjögren’s syndrome, 9 (3.5%) were African-Americans and 9 (3.5%) were Hispanic-Americans.  This was substantially below the representation of these minorities in the general population of the region (about 10% each), but was no different than that found among 273 subjects not classified as SS who had no anti-Ro/La and a focus score of 0.0.  Compared to 152 non-Hispanic white Americans classified as SS, the blacks Americans with SS were less likely to have an abnormal Schirmer’s test (1 of 9 versus 79 of 152, Fisher’s p=0.03).  Other clinical manifestations were similar between non-Hispanic whites and Blacks- or Hispanic Americans.  Both Hispanic and black SS subjects were more likely to have anti-Ro (or SSA) than non-Hispanic white SS, and black SS were also more likely to have anti-La (or SSB) (6 of 9 versus 44 of 152, Fisher’s p=0.026).  We also compared the race and ethnicity of the SS cohort to a cohort of SLE patients collected in the same geographic area.  Of 477 SLE patients, 106 were black.  This was statistically different compared to SS (9 of 152 versus 106 of 447, χ2=42.7, p>0.001, odds ratio=7.8 (95%CI=3.9-15.8)).  There were 32 Hispanics among the SLE group, and this difference almost reached statistical significance (χ2=3.27, p=0.07, OR=0.99-4.6).

Conclusion: Neither Black-Americans nor Hispanic-Americans were commonly found among a cohort with Sjögren’s syndrome.  Further, SS was not more severe in either Blacks or Hispanics. This is in contrast to SLE, where both these minority groups were over-represented among SLE, and disease is more severe.  These findings may well represent a biological difference between Sjögren’s and SLE, but socioeconomic factors impacting upon access to care and referral could be important.


Disclosure:

A. Igoe,
None;

C. J. Lessard,
None;

J. M. Anaya,
None;

A. Rasmussen,
None;

K. Grundahl,
None;

B. T. Kurien,
None;

J. S. Maier-Moore,
None;

L. Radfar,
None;

J. A. Ice,
None;

G. D. Houston,
None;

D. M. Lewis,
None;

D. U. Stone,
None;

K. S. Hefner,
None;

K. L. Sivils,
None;

R. H. Scofield,

Lily,

5.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sjogrens-syndrome-in-american-ethnic-and-racial-minorities/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology